GlaxoSmithKline Postpones Plan to Increase Stake in Nigerian Arm

GlaxoSmithKline’s UK headquarters has postponed a plan to increase its stake in GSK Nigeria after the minority shareholders shot down the deal.
Pharmaceutical Business Review